IL145921A0 - Crystalline forms of the sodium salt of 5-chloro-2-methoxy-n-(2-(4-methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide - Google Patents

Crystalline forms of the sodium salt of 5-chloro-2-methoxy-n-(2-(4-methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide

Info

Publication number
IL145921A0
IL145921A0 IL14592100A IL14592100A IL145921A0 IL 145921 A0 IL145921 A0 IL 145921A0 IL 14592100 A IL14592100 A IL 14592100A IL 14592100 A IL14592100 A IL 14592100A IL 145921 A0 IL145921 A0 IL 145921A0
Authority
IL
Israel
Prior art keywords
methoxy
methylaminothio
sulfonylphenyl
carbonylamino
benzamide
Prior art date
Application number
IL14592100A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL145921A0 publication Critical patent/IL145921A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14592100A 1999-04-16 2000-04-04 Crystalline forms of the sodium salt of 5-chloro-2-methoxy-n-(2-(4-methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide IL145921A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19917233A DE19917233A1 (de) 1999-04-16 1999-04-16 Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids
PCT/EP2000/002984 WO2000063167A1 (en) 1999-04-16 2000-04-04 Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide

Publications (1)

Publication Number Publication Date
IL145921A0 true IL145921A0 (en) 2002-07-25

Family

ID=7904803

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14592100A IL145921A0 (en) 1999-04-16 2000-04-04 Crystalline forms of the sodium salt of 5-chloro-2-methoxy-n-(2-(4-methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide
IL145921A IL145921A (en) 1999-04-16 2001-10-14 Crystallized forms of sodium salt of 5 - chloro - 2 - methoxy-4) - 2) - N - methoxy - 3 - methylamino carbonylamino sulfonyl / phenyl (ethyl) - benzamide, process for their preparation, use and medicinal preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145921A IL145921A (en) 1999-04-16 2001-10-14 Crystallized forms of sodium salt of 5 - chloro - 2 - methoxy-4) - 2) - N - methoxy - 3 - methylamino carbonylamino sulfonyl / phenyl (ethyl) - benzamide, process for their preparation, use and medicinal preparations containing them

Country Status (33)

Country Link
US (1) US6723751B1 (sk)
EP (2) EP1173418B1 (sk)
JP (1) JP4662640B2 (sk)
KR (1) KR100700302B1 (sk)
CN (1) CN1168712C (sk)
AR (1) AR023479A1 (sk)
AT (2) ATE414059T1 (sk)
AU (1) AU773246B2 (sk)
BR (1) BR0010658A (sk)
CA (1) CA2370388C (sk)
CZ (1) CZ302459B6 (sk)
DE (3) DE19917233A1 (sk)
DK (1) DK1173418T3 (sk)
EE (1) EE04612B1 (sk)
ES (1) ES2251996T3 (sk)
HK (1) HK1046270B (sk)
HR (1) HRP20010744B1 (sk)
HU (1) HU229082B1 (sk)
IL (2) IL145921A0 (sk)
ME (1) MEP55708A (sk)
MX (1) MXPA01010275A (sk)
MY (1) MY122588A (sk)
NO (1) NO327798B1 (sk)
NZ (1) NZ514788A (sk)
PL (1) PL203809B1 (sk)
RS (1) RS50916B (sk)
RU (1) RU2235089C2 (sk)
SI (1) SI1173418T1 (sk)
SK (1) SK287175B6 (sk)
TR (2) TR200102993T2 (sk)
TW (1) TWI276622B (sk)
WO (1) WO2000063167A1 (sk)
ZA (1) ZA200108400B (sk)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ542852A (en) * 2003-03-17 2008-09-26 Japan Tobacco Inc Pharmaceutical compositions of CETP inhibitors
TWI393560B (zh) * 2003-05-02 2013-04-21 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2098069T3 (es) * 1993-02-23 1997-04-16 Hoechst Ag Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos.
DE19505397A1 (de) * 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
AU762832B2 (en) * 1998-09-10 2003-07-03 Sanofi-Aventis Deutschland Gmbh Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers

Also Published As

Publication number Publication date
AU773246B2 (en) 2004-05-20
MEP55708A (en) 2011-05-10
CZ302459B6 (cs) 2011-06-01
EP1637519A1 (en) 2006-03-22
HK1046270B (zh) 2005-03-11
EE04612B1 (et) 2006-04-17
PL351245A1 (en) 2003-04-07
SI1173418T1 (sl) 2006-02-28
RS50916B (sr) 2010-08-31
DE19917233A1 (de) 2000-10-19
PL203809B1 (pl) 2009-11-30
DE60024431D1 (en) 2006-01-05
MY122588A (en) 2006-04-29
JP2002542230A (ja) 2002-12-10
ZA200108400B (en) 2003-04-30
HUP0200791A3 (en) 2005-04-28
JP4662640B2 (ja) 2011-03-30
AU4542800A (en) 2000-11-02
HRP20010744B1 (en) 2010-08-31
NO20015014L (no) 2001-10-15
ES2251996T3 (es) 2006-05-16
EP1637519B1 (en) 2008-11-12
SK14582001A3 (sk) 2002-01-07
CA2370388A1 (en) 2000-10-26
DE60024431T2 (de) 2006-07-27
MXPA01010275A (es) 2003-07-21
TR200501142T2 (tr) 2005-08-22
ATE414059T1 (de) 2008-11-15
HK1046270A1 (en) 2003-01-03
NZ514788A (en) 2003-03-28
HUP0200791A2 (hu) 2002-07-29
ATE311364T1 (de) 2005-12-15
US6723751B1 (en) 2004-04-20
SK287175B6 (sk) 2010-02-08
AR023479A1 (es) 2002-09-04
WO2000063167A1 (en) 2000-10-26
HRP20010744A2 (en) 2003-04-30
TWI276622B (en) 2007-03-21
KR100700302B1 (ko) 2007-03-29
CN1354744A (zh) 2002-06-19
KR20010109355A (ko) 2001-12-08
RU2235089C2 (ru) 2004-08-27
CN1168712C (zh) 2004-09-29
EP1173418A1 (en) 2002-01-23
IL145921A (en) 2006-07-05
DK1173418T3 (da) 2006-04-10
BR0010658A (pt) 2002-02-19
CA2370388C (en) 2009-10-13
CZ20013672A3 (cs) 2002-01-16
NO20015014D0 (no) 2001-10-15
TR200102993T2 (tr) 2002-03-21
NO327798B1 (no) 2009-09-28
DE60040811D1 (de) 2008-12-24
YU72001A (sh) 2004-07-15
HU229082B1 (hu) 2013-07-29
EP1173418B1 (en) 2005-11-30
EE200100532A (et) 2002-12-16

Similar Documents

Publication Publication Date Title
HK1026699A1 (en) Crystalline form of omeprazole sodium salt
HUP0202536A3 (en) Crystals of the sodium salt of pravastatin
IL149118A0 (en) Inhibitors of neuraminidases
HK1041259A1 (en) Novel crystalline form of the potassium salt of (s)- omeprazole
GB0013383D0 (en) Therapeutic benzamide derivatives
HK1053657A1 (en) Novel heterocyclic compounds and salts thereof andmedicinal use of the same
EP1149843A4 (en) SUBSTITUTED PHENETHYLAMINE DERIVATIVES
GB0013346D0 (en) Therapeutic benzamide derivatives
IL145921A0 (en) Crystalline forms of the sodium salt of 5-chloro-2-methoxy-n-(2-(4-methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide
EE200100381A (et) Morfolinobensamiidi uued soolad
IL140766A0 (en) Novel salts of n-tert-butylhydroxylamine
IL150245A0 (en) Process for the preparation of sodium salts of statins
MA26840A1 (fr) Cristaux d'inhibiteur d'echangeur sodium-hydrogene de type 1
HU9904011D0 (en) Novel salts of dipeptid derivatives
GB0109287D0 (en) Therapeutic benzamide derivatives
SI0991641T1 (en) Crystalline form of omeprazole sodium salt
GB9929412D0 (en) Use of salt water
ZA9810653B (en) Insecticidal photostable acid salt derivatives of N-benzyl-4-benzhydrolpiperidines
GB0013377D0 (en) Therapeutic benzamide derivatives
GB0013389D0 (en) Therapeutic benzamide derivatives
GB0013386D0 (en) Therapeutic benzamide derivatives
GB0013387D0 (en) Therapeutic benzamide derivatives
IT1303734B1 (it) Forma cristallina del diclofenac sale sodico.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed